Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Clin Pharmacol Ther. 2011 Jun 29;90(2):279–286. doi: 10.1038/clpt.2011.124

Figure 4. Differential modulation of serum unconjugated bile acids by fenofibrate in men and women.

Figure 4

Non-cholestatic volunteers received a 3-week treatment with fenofibrate, and serum bile acids were determined in sera from each donor drawn before and after fenofibrate exposure. All values represent mean ± S.E.M.
Inline graphic : Men pre-treatment; Inline graphic : Men post-treatment
Inline graphic : Women pre-treatment; Inline graphic : Women post-treatment

Statistically significant differences in pre- versus post-fenofibrate samples from men or women were determined by the Wilcoxon matched-pairs signed-ranks test *, p<0.05; **, p<0.01; ***, p<0.001; n.s., not significant. CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; HCA, hyocholic acid; HDCA, hyodeoxycholic acid; LCA, lithocholic acid; LCA-S, LCA-sulfate; UDCA, ursodeoxycholic acid.